A Win For Aridis Pharmaceuticals, Inc.
Fri, Jan 21, 2022 at 05:35 PM
Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ) soared at $1.6, a gain of 20.3%. On Thu, Jan 20, 2022, ARDS:NASDAQ hit a New 2-Week Low of $1.33. The stock got featured on our News Catalysts scanner on Wed, Dec 29, 2021 at 02:05 PM in the 'MISCELLANEOUS' category. From Fri, Jan 07, 2022, the stock recorded 12.50% Up Days and 22.22% Green Days
The stock spiked on Tue, Dec 21, 2021 at $4.34 with a volume of 43M+.
About Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ)
Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.
Top 10 Gainers:
- Canna-Global Acquisition Corp (CNGL:NASDAQ), 100%
- Pintec Technology Holdings Limited (PT:NASDAQ), 55.31%
- BBQ Holdings, Inc. (DAVE:NASDAQ), 30.25%
- CF Acquisition Corp. V (CFV:NASDAQ), 30.2%
- Save Foods Inc. (SVFD:NASDAQ), 25.6%
- Vistas Media Acquisition Company Inc. (VMAC:NASDAQ), 25.38%
- Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ), 20.3%
- Mainz Biomed B.V. (MYNZ:NASDAQ), 16.88%
- Eco Wave Power Global AB (publ) (WAVE:NASDAQ), 16.43%
- Gelesis Holdings Inc. (GLS:NYSE), 15.11%